TherapeuticsMD TXMD Earnings Call Transcripts

NASDAQ TXMD
$1.74 +0.06 (+3.57%)
At close: Nov 10, 2026 · 4:00 PM EST
10 earnings calls on file for TherapeuticsMD, from Q4 2019 to Q2 2022. Each transcript opens in a new tab.
Latest earnings call

TherapeuticsMD Q2 2022 Earnings Call

Aug 15, 2022 3,476 words · 15 min read
  • Lisa WilsonInvestor Relations
  • Hugh O'DowdChief Executive Officer
  • Michael DoneganInterim Chief Financial Officer
  • Mark GlickmanChief Commercial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

TherapeuticsMD Earnings Call Transcripts

Calls10
LatestAug 15, 2022
SinceQ4 2019

Fiscal 2022

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 10 TherapeuticsMD transcripts Register to get access to TherapeuticsMD’s earnings call transcripts.